Dexketoprofen and Etoricoxib in Patients Undergoing Hip Arthroplasty
NCT ID: NCT02568735
Last Updated: 2016-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
24 participants
INTERVENTIONAL
2013-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)
NCT00820027
A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)
NCT00788710
High-Dose Steroid for Knee Arthroplasty Patients Expected to Have Postoperative Pain
NCT03763734
Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial
NCT07037888
Does Optimal Control of Pre-operative Chronic and Acute Pain Predict Improved Function After Orthopedic Surgery?
NCT00581685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Etoricoxib
Etoricoxib 60mg if body weight≤ 60kg, 90mg if body weight 61-90kg and 120mg if body weight\> 90kg by mouth
Etoricoxib
After total hip replacement surgery patient were given either etoricoxib or dexketoprofen
Dexketoprofen
Dexketoprofen 0,5 mg/kg up to 50 mg intravenously
Dexketoprofen
After total hip replacement surgery patient were given either etoricoxib or dexketoprofen
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexketoprofen
After total hip replacement surgery patient were given either etoricoxib or dexketoprofen
Etoricoxib
After total hip replacement surgery patient were given either etoricoxib or dexketoprofen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologist s physical status classification 1-3
* elective hip arthroplasty planned
* no contraindications to the study drugs
* no contraindication to lumbar puncture
Exclusion Criteria
* age less than 40 or over 75 years
* Planned anesthesia method other than spinal anesthesia
* contraindications to the study drugs
* Contraindications to lumbar puncture
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kuopio University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merja Kokki
MD, PhD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUH30062008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.